Your browser doesn't support javascript.
loading
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109).
Kurreck, A; Geissler, M; Martens, U M; Riera-Knorrenschild, J; Greeve, J; Florschütz, A; Wessendorf, S; Ettrich, T; Kanzler, S; Nörenberg, D; Seidensticker, M; Held, S; Buechner-Steudel, P; Atzpodien, J; Heinemann, V; Stintzing, S; Seufferlein, T; Tannapfel, A; Reinacher-Schick, A C; Modest, D P.
Afiliación
  • Kurreck A; Department of Hematology, Oncology, and Tumor Immunology (CVK/CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
  • Geissler M; Klinikum Esslingen, Esslingen, Germany.
  • Martens UM; Klinik für Innere Medizin III, SLK-Kliniken Heilbronn, Heilbronn, Germany.
  • Riera-Knorrenschild J; Universitätsklinik Marburg, Marburg, Germany.
  • Greeve J; St. Vincenz-Krankenhaus Paderborn, Paderborn, Germany.
  • Florschütz A; Stadtisches Klinikum Dessau, Dessau, Germany.
  • Wessendorf S; Klinikum Esslingen, Esslingen, Germany.
  • Ettrich T; Universitätsklinikum Ulm, Ulm, Germany.
  • Kanzler S; Leopoldina Krankenhaus, Schweinfurt, Germany.
  • Nörenberg D; Medical Faculty Mannheim, Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
  • Seidensticker M; Klinik Und Poliklinik für Radiologie, LMU Klinikum, München, Germany.
  • Held S; ClinAssess, Leverkusen, Germany.
  • Buechner-Steudel P; Universitätsklinikum Halle (Saale), Halle, Germany.
  • Atzpodien J; Franziskus-Hospital Harderberg, Georgsmarienhütte, Germany.
  • Heinemann V; Department of Medicine III and Comprehensive Cancer Center, University Hospital Munich (LMU), Munich, Germany.
  • Stintzing S; German Cancer Consortium (DKTK), German Cancer Research Center, Heidelberg, Germany.
  • Seufferlein T; Department of Hematology, Oncology, and Tumor Immunology (CVK/CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
  • Tannapfel A; Universitätsklinikum Ulm, Ulm, Germany.
  • Reinacher-Schick AC; Institute of Pathology, Ruhr-University Bochum, Bochum, Germany.
  • Modest DP; Department of Hematology, Oncology and Palliative Care, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
J Cancer Res Clin Oncol ; 146(10): 2681-2691, 2020 Oct.
Article en En | MEDLINE | ID: mdl-32449003
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas B-raf / Mutación Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Cancer Res Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas B-raf / Mutación Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Cancer Res Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Alemania